The lack of a quick, accurate point-of-care objective measurement of cognitive function presents significant challenges in healthcare, increasing the risk of missed early detection, misdiagnosis of disease, improper medication management and delaying both the detection and intervention of cognitive conditions.

The lack of a quick, accurate point-of-care objective measurement of cognitive function presents significant challenges in healthcare, increasing the risk of missed early detection, misdiagnosis of disease, improper medication management and delaying both the detection and intervention of cognitive conditions.

In the last week and a half, we have built relationships with key leaders in the space to aid in clinical adoption, research validation and commercialization of NeuroCatch. 

"This is the best accelerator I have ever attended. It represents a dynamic movement of like-minded companies, researchers, and collaborators dedicated to making a tangible impact and driving innovation in healthcare. I genuinely believe this accelerator plays a pivotal role in advancing healthcare innovation. Thanks to the exceptional support provided by the hosts, all participating companies are positioned to become leaders in their fields, ultimately bringing transformative solutions to the world."

Derek Norsworthy
CEO, NeuroCatch